Hepatitis A Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Hepatitis A Vaccine Trends and Forecast

The future of the global hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets. The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

A more than 150-page report is developed to help in your business decisions.

Hepatitis A Vaccine by Segment

The study includes a forecast for the global hepatitis A vaccine by type, application, and region.

Hepatitis A Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Inactivated Vaccine
• Live Attenuated Vaccine

Hepatitis A Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Government Institution
• Private Sector
• Others

Hepatitis A Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Hepatitis A Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis A vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis A vaccine companies profiled in this report include-

• Glaxosmithkline
• Merck & Co
• Sanofi
• Sinovac
• Zhejiang Pukang
• Changchun Institute Of Biological
• KM Biologics
• IMBCA
• Changsheng
• Convac

Hepatitis A Vaccine Market Insights

Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Within this market, government institution is expected to witness higher growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Features of the Global Hepatitis A Vaccine Market

Market Size Estimates: Hepatitis a vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hepatitis a vaccine market size by type, application, and region in terms of value ($B).

Regional Analysis: Hepatitis a vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis A vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis A vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the hepatitis A vaccine market size?

Answer: The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030.

Q.2 What is the growth forecast for hepatitis A vaccine market?

Answer: The global hepatitis A vaccine market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the hepatitis A vaccine market?

Answer: The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

Q4. What are the major segments for hepatitis A vaccine market?

Answer: The future of the hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets.

Q5. Who are the key hepatitis A vaccine market companies?

Answer: Some of the key hepatitis A vaccine companies are as follows:

• Glaxosmithkline
• Merck & Co
• Sanofi
• Sinovac
• Zhejiang Pukang
• Changchun Institute Of Biological
• KM Biologics
• IMBCA
• Changsheng
• Convac

Q6. Which hepatitis A vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Q7. In hepatitis A vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hepatitis A vaccine market by type (inactivated vaccine and live attenuated vaccine), application (government institution, private sector, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?